Rafika Jarray - Concepedia

Author

Rafika Jarray

Centre National de la Recherche Scientifique

Also Known As

Rafika Jarray

Publications

591

Citations

H-Index

Concepts

All Affiliations

Centre National de la Recherche Scientifique Inserm Commissariat à l'Énergie Atomique et aux Énergies Alternatives Institut Supérieur des Biotechnologies de Paris Sorbonne Paris Cité

About

Rafika Jarray is an author at Centre National de la Recherche Scientifique specializing in medicine, cell biology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	497
2	Social Sciences	2	2	121
3	Health Sciences	1	1	21
4	Biochemistry	1	1	53
5	Biomolecular Engineering	1	1	63

Rafika Jarray

Publications

574

Citations

H-Index

Page 1

	Year	Citations
Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes Serena Pavoni, Rafika Jarray, Férid Nassor, PLoS ONE Aβ-42 Peptide ProductionProtein SecretionSynaptic TransmissionHuman Mini-brainsCerebral Organoid	2018	87
Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells Barbara Allain, Rafika Jarray, Lucia Borriello, Cellular Signalling Developmental BiologyAngiogenesisSignaling PathwayCell SignalingNew Vegf-induced Gene	2011	73
Depletion of the novel protein PHACTR-1 from human endothelial cells abolishes tube formation and induces cell death receptor apoptosis Rafika Jarray, Barbara Allain, Lucia Borriello, Biochimie AngiogenesisSignal TransductionSignaling PathwayApoptosisImmunology	2011	65
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model G. Le Roux, Rafika Jarray, Anne-Cécile Guyot, Scientific Reports	2019	64
Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity Pascal Dao, Rafika Jarray, Johanne Le Coq, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAnti-angiogenic ActivityNovel Diarylamino-1,3,5-triazine DerivativesMedicineDrug Discovery	2013	63
Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model Lucia Borriello, Matthieu Montès, Yves Lepelletier, Cancer Letters BiochemistryMedicineRational Drug DesignVivo Anti-tumor ActivityAnti-cancer Agent	2014	53
NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model Wang‐Qing Liu, Yves Lepelletier, Matthieu Montès, Cancer Letters Mouse Xenograft ModelAngiogenesisMedicineEndothelial DysfunctionVivo Anti-cancer Effects	2017	50
Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: New insights in atherosclerosis development Rafika Jarray, Serena Pavoni, Lucia Borriello, Biochimie InflammationMetabolic SyndromeVascular DiseaseAtherosclerosis DevelopmentAtherosclerosis	2015	41
Long Term Gene Expression in Human Induced Pluripotent Stem Cells and Cerebral Organoids to Model a Neurodegenerative Disease Férid Nassor, Rafika Jarray, Denis Biard, Frontiers in Cellular Neuroscience Cerebral OrganoidSocial SciencesNeuroregenerationEpstein-barr VirusStem Cells	2020	34
Inhibition of both focal adhesion kinase and fibroblast growth factor receptor 2 pathways induces anti-tumor and anti-angiogenic activities Pascal Dao, Rafika Jarray, Nikaïa Smith, Cancer Letters Tumor BiologyAngiogenesisFocal Adhesion KinaseReceptor Tyrosine KinasePathways Induces	2014	21

Page 1